Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner
Authors:
- 18 June 2015
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 30 (2) , 508-513
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemiaBlood, 2012
- Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaNature Chemical Biology, 2012
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genomeBlood, 2011
- Molecular Basis of the Mixed Lineage Leukemia-Menin InteractionJournal of Biological Chemistry, 2010
- The molecular biology of mixed lineage leukemiaHaematologica, 2009
- Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cellsLeukemia, 2006
- Chromosomal Aberration of the 11q23 Locus in Acute Leukemia and Frequency ofMLLGene TranslocationAmerican Journal of Clinical Pathology, 2004
- Chromosomal Aberration of the 11q23 Locus in Acute Leukemia and Frequency of MLL Gene Translocation Results in 378 Adult PatientsAmerican Journal of Clinical Pathology, 2004
- MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemiaNature Genetics, 2001